164 related articles for article (PubMed ID: 15058300)
1. Neuroprotection abilities of cytosolic phospholipase A2 inhibitors in kainic acid-induced neurodegeneration.
Farooqui AA; Ong WY; Horrocks LA
Curr Drug Targets Cardiovasc Haematol Disord; 2004 Mar; 4(1):85-96. PubMed ID: 15058300
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of cytosolic phospholipase A2 as mediator of the enhanced arachidonic acid release from dimethyl sulphoxide differentiated U937 cells.
Withnall MT; Pennington A; Wiseman D
Biochem Pharmacol; 1995 Nov; 50(11):1893-902. PubMed ID: 8615870
[TBL] [Abstract][Full Text] [Related]
3. Structure, function and regulation of Ca2+-sensitive cytosolic phospholipase A2 (cPLA2).
Kramer RM; Sharp JD
FEBS Lett; 1997 Jun; 410(1):49-53. PubMed ID: 9247121
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders.
Farooqui AA; Ong WY; Horrocks LA
Pharmacol Rev; 2006 Sep; 58(3):591-620. PubMed ID: 16968951
[TBL] [Abstract][Full Text] [Related]
5. Cloning and expression of a group IV cytosolic Ca2+-dependent phospholipase A2 from rat pancreatic islets. Comparison of the expressed activity with that of an islet group VI cytosolic Ca2+-independent phospholipase A2.
Ma Z; Ramanadham S; Hu Z; Turk J
Biochim Biophys Acta; 1998 Apr; 1391(3):384-400. PubMed ID: 9555100
[TBL] [Abstract][Full Text] [Related]
6. Mediators of injury in neurotrauma: intracellular signal transduction and gene expression.
Bazan NG; Rodriguez de Turco EB; Allan G
J Neurotrauma; 1995 Oct; 12(5):791-814. PubMed ID: 8594208
[TBL] [Abstract][Full Text] [Related]
7. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2.
Bonventre JV; Huang Z; Taheri MR; O'Leary E; Li E; Moskowitz MA; Sapirstein A
Nature; 1997 Dec; 390(6660):622-5. PubMed ID: 9403693
[TBL] [Abstract][Full Text] [Related]
8. Synthetic and natural inhibitors of phospholipases A2: their importance for understanding and treatment of neurological disorders.
Ong WY; Farooqui T; Kokotos G; Farooqui AA
ACS Chem Neurosci; 2015 Jun; 6(6):814-31. PubMed ID: 25891385
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cytosolic phospholipase A2 in hen granulosa cells by transforming growth factors at different stages of follicular development.
Li J; Li M; Tsang BK
Biol Reprod; 1997 Oct; 57(4):929-35. PubMed ID: 9314599
[TBL] [Abstract][Full Text] [Related]
10. PARP Inhibition Prevents Ethanol-Induced Neuroinflammatory Signaling and Neurodegeneration in Rat Adult-Age Brain Slice Cultures.
Tajuddin N; Kim HY; Collins MA
J Pharmacol Exp Ther; 2018 Apr; 365(1):117-126. PubMed ID: 29339456
[TBL] [Abstract][Full Text] [Related]
11. Cytosolic phospholipase A2 (cPLA2) and lipid mediator release in the brain.
Kramer RM; Stephenson DT; Roberts EF; Clemens JA
J Lipid Mediat Cell Signal; 1996 Sep; 14(1-3):3-7. PubMed ID: 8906538
[TBL] [Abstract][Full Text] [Related]
12. Phospholipase A2.
Murakami M; Kudo I
J Biochem; 2002 Mar; 131(3):285-92. PubMed ID: 11872155
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection of rat hippocampal slices exposed to oxygen-glucose deprivation by enrichment with docosahexaenoic acid and by inhibition of hydrolysis of docosahexaenoic acid-containing phospholipids by calcium independent phospholipase A2.
Strokin M; Chechneva O; Reymann KG; Reiser G
Neuroscience; 2006 Jun; 140(2):547-53. PubMed ID: 16563639
[TBL] [Abstract][Full Text] [Related]
14. [Phospholipase A2--from basic research to clinical reality].
Schoenberg MH; Mayer JM; Beger HG
Chirurg; 1997 Nov; 68(11):1112-8. PubMed ID: 9518201
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma induces the synthesis and activation of cytosolic phospholipase A2.
Wu T; Levine SJ; Lawrence MG; Logun C; Angus CW; Shelhamer JH
J Clin Invest; 1994 Feb; 93(2):571-7. PubMed ID: 8113394
[TBL] [Abstract][Full Text] [Related]
16. Regulation of leukotriene and platelet-activating factor synthesis in human alveolar macrophages.
Shamsuddin M; Chen E; Anderson J; Smith LJ
J Lab Clin Med; 1997 Dec; 130(6):615-26. PubMed ID: 9422335
[TBL] [Abstract][Full Text] [Related]
17. Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells.
Fonteh AN; Atsumi G; LaPorte T; Chilton FH
J Immunol; 2000 Sep; 165(5):2773-82. PubMed ID: 10946309
[TBL] [Abstract][Full Text] [Related]
18. Involvement of cytosolic phospholipase A2 and secretory phospholipase A2 in arachidonic acid release from human neutrophils.
Marshall J; Krump E; Lindsay T; Downey G; Ford DA; Zhu P; Walker P; Rubin B
J Immunol; 2000 Feb; 164(4):2084-91. PubMed ID: 10657662
[TBL] [Abstract][Full Text] [Related]
19. Phospholipase A2, oxidative stress, and neurodegeneration in binge ethanol-treated organotypic slice cultures of developing rat brain.
Moon KH; Tajuddin N; Brown J; Neafsey EJ; Kim HY; Collins MA
Alcohol Clin Exp Res; 2014 Jan; 38(1):161-9. PubMed ID: 23909864
[TBL] [Abstract][Full Text] [Related]
20. Recent insights into the structure, function and biology of cPLA2.
Kramer RM; Sharp JD
Agents Actions Suppl; 1995; 46():65-76. PubMed ID: 7610992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
